Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
101.10
-3.65 (-3.48%)
Feb 11, 2026, 4:00 PM EST - Market closed
Revvity Revenue
In the year 2025, Revvity had annual revenue of $2.86B with 3.67% growth. Revvity had revenue of $772.06M in the quarter ending December 28, 2025, with 5.85% growth.
Revenue (ttm)
$2.86B
Revenue Growth
+3.67%
P/S Ratio
4.13
Revenue / Employee
$259,641
Employees
11,000
Market Cap
11.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2025 | 2.86B | 101.03M | 3.67% |
| Dec 29, 2024 | 2.76B | 4.46M | 0.16% |
| Dec 31, 2023 | 2.75B | -561.25M | -16.95% |
| Jan 1, 2023 | 3.31B | -515.99M | -13.48% |
| Jan 2, 2022 | 3.83B | 1.16B | 43.73% |
| Jan 3, 2021 | 2.66B | -220.44M | -7.64% |
| Dec 29, 2019 | 2.88B | 105.68M | 3.80% |
| Dec 30, 2018 | 2.78B | 521.01M | 23.08% |
| Dec 31, 2017 | 2.26B | 141.47M | 6.69% |
| Jan 1, 2017 | 2.12B | 10.69M | 0.51% |
| Jan 3, 2016 | 2.10B | 34.94M | 1.69% |
| Dec 28, 2014 | 2.07B | -87.71M | -4.07% |
| Dec 29, 2013 | 2.16B | 52.40M | 2.49% |
| Dec 30, 2012 | 2.11B | 186.68M | 9.73% |
| Jan 1, 2012 | 1.92B | 216.74M | 12.74% |
| Jan 2, 2011 | 1.70B | 151.00M | 9.74% |
| Jan 3, 2010 | 1.55B | -108.90M | -6.56% |
| Dec 28, 2008 | 1.66B | -69.21M | -4.00% |
| Dec 30, 2007 | 1.73B | 251.19M | 17.00% |
| Dec 31, 2006 | 1.48B | 3.85M | 0.26% |
| Jan 1, 2006 | 1.47B | 44.74M | 3.13% |
| Jan 2, 2005 | 1.43B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Labcorp Holdings | 13.77B |
| Quest Diagnostics | 10.85B |
| ICON Public Limited Company | 8.10B |
| Illumina | 4.34B |
| Charles River Laboratories International | 4.02B |
| Waters | 3.17B |
| Exact Sciences | 3.08B |
| Medpace Holdings | 2.36B |
RVTY News
- 6 days ago - Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026 - Business Wire
- 8 days ago - Revvity: Close To A Buy, Not Quite There - Seeking Alpha
- 8 days ago - Revvity Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results - Benzinga
- 9 days ago - Revvity, Inc. (RVTY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Revvity Sees Steady Growth On Rising Demand From Pharma/Biotech Customers - Benzinga
- 9 days ago - Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter - Reuters
- 9 days ago - Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2025 - Business Wire
- 16 days ago - Revvity Board Declares Quarterly Dividend - Business Wire